![]() |
市場調査レポート
商品コード
1397179
血流測定装置の世界市場:洞察、競合情勢、市場予測:2028年Blood Flow Measurement Devices - Market Insights, Competitive Landscape and Market Forecast-2028 |
||||||
カスタマイズ可能
|
血流測定装置の世界市場:洞察、競合情勢、市場予測:2028年 |
出版日: 2023年12月18日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 1~3営業日
|
世界の血流測定装置の市場規模は、2023年から2028年までの予測期間中に9.1%のCAGRで拡大すると予測されています。血流測定装置の需要は、世界中で様々な心血管疾患、糖尿病、その他の慢性疾患の症例が増加していることが背景にあります。さらに、心血管手術、腹腔鏡手術、その他の手術の増加、製品技術の進歩、高齢者人口の増加、製品の発売と承認の増加なども、2023年から2028年の予測期間中の血流測定装置市場の全体的な成長に寄与しています。
血流測定装置市場は、さまざまな要因によって製品需要が伸びていますが、主要な要因の1つは、脳卒中、心臓発作などの心疾患の有病率の増加です。
例えば、米国疾病予防管理センター(CDC)2022によると、毎年米国では約80万5,000人が心臓発作を起こし、このうち60万5,000人が初めて心臓発作を起こし、20万件近くがすでに心臓発作を起こした人に起きています。血流モニタリング装置は心臓発作患者の管理において重要な役割を果たし、ヘルスケアプロバイダーは介入の有効性を評価し、治癒の経過をモニターし、治療戦略を最適化することができます。このように、血流モニタリング装置は、より良い心血管治療、個別化された治療、心臓発作リスクのある個人の転帰改善に貢献するため、心血管疾患の有病率の増加とともに需要が増加すると予想されます。
血流装置測定市場は、最先端の血流測定装置に集中するいくつかの研究開発の結果として拡大しています。例えば、Sree ChitraTirunal Institute for Medical Sciences and Technologyの研究者グループによって考案された斬新でリーズナブルな価格の血流計は、インド政府の科学技術省によって取り上げられました。研究者らは、この手のひらサイズの装置は国内および国際的な基準やガイドラインに準拠しており、国内の確立されたサプライチェーンから調達した部品を使用して製造されていると主張しました。この装置は、新しい磁気法と信号調整技術を用いて血流量を測定します。こうした要因が2023~2028年の予測期間中の血流測定装置市場の成長に寄与しています。
しかし、装置の高コスト、精度や偽結果の懸念などが、血流測定装置の市場成長を制限する可能性があります。
当レポートでは、世界の血流測定装置市場について調査し、市場の概要とともに、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Blood Flow Measurement Devices Market By Product (Ultrasound Devices [Ultrasound Doppler And Transit-Time Flow Meters] And Laser Doppler Flow Meter), Application (Invasive And Non-Invasive), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the increasing prevalence of cardiovascular diseases and the rising demand of biodegradable blood flow sensors across the globe.
The global blood flow measurement devices market is estimated to grow at a CAGR of 9.1% during the forecast period from 2023 to 2028. The demand for blood flow measurement devices is being boosted due to the rising cases of various cardiovascular diseases, diabetes, and other chronic diseases across the globe. Further, the increasing number of cardiovascular surgeries, laparoscopic surgery, and other surgeries along with the advancements in product technologies, rising geriatric population base, rising product launches and approvals, among others are also contributing to the overall growth of the blood flow measurement devices market during the forecast period from 2023-2028.
The blood flow measurement devices market is witnessing a growth in product demand owing to various factors, one of the key factors is the increase in the prevalence of cardiac diseases such as stroke, heart attack, and others.
For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, every year, about 805,000 people in the United States have a heart attack, and out of these, 605,000 people suffer from their first heart attack and nearly 200,000 cases happen to people who already had a heart attack. Blood flow monitoring devices play a crucial role in managing heart attack patients, allowing healthcare providers to assess the effectiveness of interventions, monitor healing progress, and optimize treatment strategies. Thus, the demand for blood flow monitoring devices is expected to increase with the increasing prevalence of cardiovascular diseases as they contribute to better cardiovascular care, personalized treatment, and improved outcomes in individuals at risk of heart attacks.
According to the Organization for Economic Co-operation and Development (OECD) 2023, in 2021 the cases of laparoscopic appendectomy in Denmark were 7064 and the cases of laparoscopic cholecystectomy were 7672. Laparoscopic surgeries, often require precise manipulation of tissues and organs, which can potentially impact blood flow in the surgical site. To ensure optimal patient outcomes, surgeons need accurate real-time information on blood flow during these procedures, ultimately increasing the demand for blood flow measurement devices, and thereby propelling the overall market of blood flow measurement devices in the market.
The market for blood flow device measurement is expanding as a result of several research and development studies that concentrate on cutting-edge blood flow measurement devices. For instance, a novel, reasonably priced blood flow meter devised by a group of researchers at the Sree ChitraTirunal Institute for Medical Sciences and Technology was addressed by the Government of India's Ministry of Science & Technology. The researchers claimed that the palm-sized device complies with national and international standards and guidelines and is manufactured using components sourced from well-established supply chains domestically. It measures blood flow rate using a novel magnetic method and a signal conditioning technique.
Therefore, the above-mentioned factors are contributing to the growth of the blood flow measurement devices market during the forecast period from 2023-2028.
However, the high cost of the device, accuracy or false result concerns, and others may restrict the blood flow measurement device's market growth.
Blood flow measurement devices market by Product (Ultrasound Devices [Ultrasound Doppler and Transit-Time Flow Meters] and Laser Doppler Flow Meter), Application (Invasive and Non-Invasive), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the application segment of the blood flow measurement device non-invasive blood flow category is expected to amass significant revenue share in the year 2023. This can be due to the significant advantages of non-invasive techniques.
These devices provide a non-invasive method of measuring blood flow, eliminating the need for invasive procedures and reducing patient discomfort and potential complications. The convenience and ease of use associated with non-invasive blood flow meters make them suitable for a wide range of healthcare professionals and medical disciplines.
Additionally, because they offer a patient-centric approach to healthcare, their capacity to increase patient comfort and happiness contributes to their expanding demand. Thus, increased demand for non-invasive blood flow meters is being driven positively by the benefits of convenience, patient comfort, adaptability, and alignment with preventative healthcare across a range of medical specializations and healthcare settings.
Furthermore, coupled with the factors mentioned above, strategic activities such as product launches and approvals will also increase the demand for non-invasive blood flow meters. For instance, in March 2020, the FDA approved a flow patch, a non-invasive cardiovascular blood flowmeter, by Flosonics Medical. FloPatch is the world's first wireless, wearable Doppler ultra-sound system that helps clinicians better manage intravenous (IV) fluid therapy earlier in the sepsis care pathway. Thus, such strategic steps help to increase the demand for non-invasive blood flow meter devices.
Therefore, the advantages offered by non-invasive blood flow measurement devices, increasing product launches and approvals, and others are predicted to contribute to the increasing demand for this category, thereby driving the growth of the overall blood flow measurement devices market during the forecast period.
Among all the regions, North America is estimated to account for the largest share in the blood flow measurement devices market in the year 2022 owing to key growth factors such as the rising prevalence of coronary heart diseases, increasing number of surgeries, and others. Additionally, the rise in the adoption of highly advanced techniques and systems in the manufacturing of blood flow measurement devices, the increasing product launches, surging technological advancements, and others are driving the North American blood flow measurement devices market. Furthermore, sophisticated healthcare infrastructure, regulatory approval for new products, and others also helped the market growth in this region.
As per the Department of Health New York State (2020), coronary heart disease (CHD) is the most common type of heart disease, killing approximately 382,820 people annually, in the US. Also, every year about 805,000 Americans have a heart attack. The source also stated that an estimated 18.9% of New Yorkers aged 65 and older reported having some type of Cardiovascular Disease (CVD) in 2020. Blood flow monitoring devices provide valuable information about the rate, velocity, and quality of blood flow, allowing healthcare professionals to evaluate the severity of arterial blockages, monitor the effectiveness of interventions, and guide treatment decisions that can manage life-threatening conditions in cardiovascular illness. Thus, the demand for blood flow monitoring devices is increasing as a result of the rising frequency of cardiovascular illnesses.
Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in June 2023, US-based digital health company STAT Health introduced a 24/7 in-ear wearable general wellness product that measures blood flow to the head to allow a better understanding of conditions in the body that occur upon standing. Therefore, such strategic steps help to increase the demand for blood flow monitoring devices in the North America region.
Therefore, the factors mentioned above help in boosting regional product demand. Thereby, driving the North American blood flow measurement devices market forward during the forecast period.
Some of the key market players operating in the blood flow measurement devices market include: Cook, Medistim, Compumedics Limited, Permed AB, Deltex Medical Limited, Koninklijke Philips N.V., Getinge, Arjo, ATYS Medical, Moor Instruments Limited, Medtronic, AKW Medical, Inc., D. E. Hokanson, Inc., ELCAT GmbH, Oxford Optronix, QT Medical Inc. Transonic, Carolina Medical Electronics, ADINSTRUMENTS, STAT Health Informatics, Inc., and others.